The Role of HB-EGF in Renal Epithelial Cell Injury
HB-EGF 在肾上皮细胞损伤中的作用
基本信息
- 批准号:7339831
- 负责人:
- 金额:$ 31.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-15 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnoikisApoptosisCell CommunicationCell PolarityCell physiologyCell-Cell AdhesionCell-Matrix JunctionCellsChimera organismChronicChronic Kidney FailureDTR geneDevelopmentDisruptionDistalElementsEngineeringEpidermal Growth FactorEpidermal Growth Factor ReceptorEpithelial CellsErbB4 geneGlycoproteinsGrowth FactorHeparinHeparin BindingInhibition of ApoptosisInjuryInorganic SulfatesIntegrinsInternetKidneyLeadMediatingMediationMediator of activation proteinMembraneMusMutationNatural regenerationNephronsPlayPrincipal InvestigatorProtein OverexpressionProteinsRecoveryRelative (related person)ResistanceRoleScaffolding ProteinSignal PathwaySignal TransductionStructureTestingTransgenic MiceUnspecified or Sulfate Ion Sulfatesautocrinecell injurycell motilitydiphtheria toxin receptorheparin-binding EGF-like growth factorhuman PHEMX proteinin vivoparacrinepreventprogramsrecombinaseresponsescaffold
项目摘要
There is increasing evidence for a role for EGF receptor (EGFR; HER1) activation in recovery from acute renal injury. Expression of heparin-binding epidermal growth factor (HB-EGF), which signals through EGFR as well as HER4, increases in the mammalian kidney in response to acute injury. The precursor for soluble HB-EGF is membrane-associated HB-EGF (proHB-EGF). We hypothesize that in renal epithelial cells, proHB-EGF mediates different cellular functions than soluble HB-EGF. We propose that proHBEGF helps to maintain epithelial cell polarity, integrity and differentiation by: 1) juxtacrine signaling through EGFR and/or HER4; and 2) serving as a scaffold for membrane-associated and cytoskeletal elements (tetraspanins, integrins and glycoproteins) that promote cell-cell interactions. Therefore, cleavage of proHB-EGF may lead to cell activation by release of soluble HB-EGF that can serve as an autocrine and paracrine growth factor as well as by disruption of cell-cell, cell-ECM and cytoskeletal interactions of proHB-EGF and associated proteins that predispose the epithelial cells to motility, proliferation and dedifferentiation. Specific Aim #1 will study the role of juxtacrine activation by proHBEGF in mediation of epithelial cell-cell interactions. Specific Aim #2 will determine the role of proHBEGF's interactions with the tetraspanin-integrin web and with heparin sulfate-containing glycoproteins in mediation of cell-matrix and cell-cell interactions. Specific Aim #3 will investigate the mechanisms by which proHB-EGF protects renal epithelial cells against apoptosis. For Specific Aims #1-3, we will utilize mutations and chimeras of the proHB-EGF molecule that will discriminate among EGFR activation, heparin binding, tetraspanin interaction and cytosolic protein interactions. Specific Aim #4 will utilize crosses of mice expressing floxed HB-EGF with mice expressing targeted nephron segment specific Cre recombinase, as well as transgenic mice overexpressing HB-EGF in proximal nephron, to examine the effects of altered HB-EGF expression on kidney responses to acute and progressive injury.
越来越多的证据表明EGF受体(EGFR; HER 1)活化在急性肾损伤恢复中的作用。肝素结合表皮生长因子(HB-EGF)的表达,通过EGFR以及HER 4的信号,增加在哺乳动物肾脏急性损伤的反应。可溶性HB-EGF的前体是膜结合型HB-EGF(proHB-EGF)。我们推测,在肾上皮细胞,proHB-EGF介导不同的细胞功能比可溶性HB-EGF。我们认为proHBEGF通过以下方式帮助维持上皮细胞的极性、完整性和分化:1)通过EGFR和/或HER 4的阿曲他克林信号传导; 2)作为促进细胞间相互作用的膜相关和细胞骨架元件(四跨膜蛋白、整合素和糖蛋白)的支架。因此,proHB-EGF的裂解可能通过释放可溶性HB-EGF(可作为自分泌和旁分泌生长因子)以及破坏proHB-EGF和相关蛋白的细胞-细胞、细胞-ECM和细胞骨架相互作用(使上皮细胞易于运动、增殖和去分化)而导致细胞活化。具体目标#1将研究proHBEGF的近分泌激活在介导上皮细胞与细胞相互作用中的作用。具体目标#2将确定proHBEGF与四跨膜蛋白-整联蛋白网和含硫酸肝素的糖蛋白在介导细胞-基质和细胞-细胞相互作用中的作用。具体目标#3将研究proHB-EGF保护肾上皮细胞免于凋亡的机制。对于特定目标#1-3,我们将利用proHB-EGF分子的突变和嵌合体,其将区分EGFR活化、肝素结合、四跨膜蛋白相互作用和胞质蛋白相互作用。具体目标#4将利用表达floxed HB-EGF的小鼠与表达靶向肾单位片段特异性Cre重组酶的小鼠以及在近端肾单位中过表达HB-EGF的转基因小鼠的杂交,以检查改变的HB-EGF表达对肾脏对急性和进行性损伤的反应的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND C. HARRIS其他文献
RAYMOND C. HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND C. HARRIS', 18)}}的其他基金
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
- 批准号:
10419907 - 财政年份:2022
- 资助金额:
$ 31.38万 - 项目类别:
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
- 批准号:
10611485 - 财政年份:2022
- 资助金额:
$ 31.38万 - 项目类别:
Vanderbilt O'Brien Kidney Center-Administrative Core
范德比尔特奥布莱恩肾脏中心-行政核心
- 批准号:
10163163 - 财政年份:2017
- 资助金额:
$ 31.38万 - 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
- 批准号:
8504287 - 财政年份:2013
- 资助金额:
$ 31.38万 - 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
- 批准号:
8713987 - 财政年份:2013
- 资助金额:
$ 31.38万 - 项目类别:
The Role of renal macrophages in recovery from renal injury
肾巨噬细胞在肾损伤恢复中的作用
- 批准号:
9765295 - 财政年份:2013
- 资助金额:
$ 31.38万 - 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
- 批准号:
9284449 - 财政年份:2013
- 资助金额:
$ 31.38万 - 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
- 批准号:
9067144 - 财政年份:2013
- 资助金额:
$ 31.38万 - 项目类别:
相似国自然基金
胃肠安方抑制整合素αvβ6促进胃癌细胞Anoikis防治胃癌转移的机制研究
- 批准号:82305335
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AMPK通路调控CEMIP诱导自噬对前列腺癌细胞anoikis耐受的影响及机制
- 批准号:81772751
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
Myxoma 病毒蛋白Serp-1促进肝癌细胞Anoikis的作用及机制研究
- 批准号:81372597
- 批准年份:2013
- 资助金额:16.0 万元
- 项目类别:面上项目
TrkB/BDNF通路对前列腺癌EMT、anoikis和血管生成的影响及分子机制
- 批准号:81272847
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
E-cadherin调控卵巢癌细胞anoikis-resistance的分子机制及干预
- 批准号:81172487
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
NDRG1在肝癌细胞抵抗Anoikis中的作用及其机制研究
- 批准号:30873025
- 批准年份:2008
- 资助金额:30.0 万元
- 项目类别:面上项目
肝癌细胞抵抗anoikis关键分子的筛选和鉴定
- 批准号:30700357
- 批准年份:2007
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
阻遏供体鼠胰岛整合素介导的Anoikis延长移植胰岛存活率
- 批准号:30070724
- 批准年份:2000
- 资助金额:15.0 万元
- 项目类别:面上项目
相似海外基金
Role of lncRNA UCA1 in anoikis resistantce and colorectal cancer metastasis
lncRNA UCA1在失巢凋亡抵抗和结直肠癌转移中的作用
- 批准号:
10689777 - 财政年份:2022
- 资助金额:
$ 31.38万 - 项目类别:
A Novel Anoikis Effector that Drives Ovarian Cancer Metastasis
一种驱动卵巢癌转移的新型失巢效应器
- 批准号:
10117214 - 财政年份:2020
- 资助金额:
$ 31.38万 - 项目类别:
Role of SUCLA2 in anoikis resistance and tumor metastasis
SUCLA2 在失巢凋亡抵抗和肿瘤转移中的作用
- 批准号:
10212278 - 财政年份:2020
- 资助金额:
$ 31.38万 - 项目类别:
The novel anti-cancer activities of food components: the analysis about their inhibitory functions on the invasion, growth and metastasis of cancer cells via anoikis induction
食品成分的新型抗癌活性:分析其通过失巢凋亡诱导抑制癌细胞侵袭、生长和转移的功能
- 批准号:
19K05932 - 财政年份:2019
- 资助金额:
$ 31.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The new strategy for improving of cancer prognosis - The investigation of the mechanism of food components inducing anoikis in floating cells-
改善癌症预后的新策略 - 食品成分诱导漂浮细胞失巢凋亡的机制研究 -
- 批准号:
18K05536 - 财政年份:2018
- 资助金额:
$ 31.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Selective roles of integrins in the regulation of epithelial cell anoikis
整合素在上皮细胞失巢调控中的选择性作用
- 批准号:
227935-2013 - 财政年份:2015
- 资助金额:
$ 31.38万 - 项目类别:
Discovery Grants Program - Individual
Selective roles of alpha2, alpha3 and alpha5 integrin subunits in the regulation of intestinal epithelial cell anoikis
α2、α3和α5整合素亚基在肠上皮细胞失巢凋亡调节中的选择性作用
- 批准号:
459608-2014 - 财政年份:2015
- 资助金额:
$ 31.38万 - 项目类别:
Postgraduate Scholarships - Doctoral
Selective roles of alpha2, alpha3 and alpha5 integrin subunits in the regulation of intestinal epithelial cell anoikis
α2、α3和α5整合素亚基在肠上皮细胞失巢凋亡调节中的选择性作用
- 批准号:
459608-2014 - 财政年份:2014
- 资助金额:
$ 31.38万 - 项目类别:
Postgraduate Scholarships - Doctoral
肺癌進展における細胞接着及びAnoikisに関わる新規遺伝子の解析
肺癌进展中与细胞粘附和失巢凋亡相关的新基因分析
- 批准号:
26430137 - 财政年份:2014
- 资助金额:
$ 31.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of driver genes in lung cancer through a semi-genome wide shRNA library screen based on anoikis resistance phenotype
基于失巢凋亡抗性表型的半基因组全shRNA文库筛选鉴定肺癌驱动基因
- 批准号:
26293197 - 财政年份:2014
- 资助金额:
$ 31.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




